levothyroxine sodium 0.175 MG Oral Capsule

RxCUI
1923047
RxNorm name
levothyroxine sodium 0.175 MG Oral Capsule
Display name
Levothyroxine (Oral Pill)
Full name
levothyroxine sodium 0.175 MG Oral Capsule
Term type
SCD
Status
Active
Strength
0.175 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-11-04 11:54:11

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062017
Active start
062017
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
levothyroxine sodium0.175 MG / 1 EACHlevothyroxinelevothyroxine sodium

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
levothyroxine10582

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRlevothyroxine sodium 0.175 MG Oral Capsule1NAMES
RxNorm Namelevothyroxine sodium 0.175 MG Oral Capsule1NAMES
RxNorm Synonymlevothyroxine sodium 175 MCG Oral Capsule1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDd28d7202-1278-0486-e053-2995a90af2861CODES
RxCUI19230471CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
82347-0055-482347-0055Levothyroxine Sodium levothyroxine sodiumYARAL Pharma Inc.NDA021924

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA02192482347-0055Levothyroxine Sodium levothyroxine sodiumNDA AUTHORIZED GENERICYARAL Pharma Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00527496132rxnav_ndcsyes
82347005504rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TirosintLEVOTHYROXINE SODIUMIBSA Pharma Inc.7a7ade79-0165-4e31-b84e-667416c00c7e2026-03-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1923047
Levothyroxine SodiumLEVOTHYROXINE SODIUMYARAL Pharma Inc.d28d7202-1278-0486-e053-2995a90af2862026-03-25Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 82347-0055-4
ndc (product): 82347-0055
ndc11 (package): 82347005504
rxcui: 1923047

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7a7ade79-0165-4e31-b84e-667416c00c7elevothyroxine sodium 175 MCG Oral Capsule [PSN] · levothyroxine sodium 0.175 MG Oral Capsule [SCD] · levothyroxine sodium 175 MCG Oral Capsule [SY]313These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 200020260325
d28d7202-1278-0486-e053-2995a90af286levothyroxine sodium 175 MCG Oral Capsule [PSN] · levothyroxine sodium 0.175 MG Oral Capsule [SCD] · levothyroxine sodium 175 MCG Oral Capsule [SY]37These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 200020260325

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
d28d7202-1278-0486-e053-2995a90af286These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 2000YARAL Pharma Inc.20260325
d28d7202-1278-0486-e053-2995a90af286These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 2000YARAL Pharma Inc.20260105
686ba2cf-7651-44de-9b4d-eeaaf2a0e364These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 2000Lannett Company, Inc.20240524

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCH03AAThyroid hormonesATC1-4levothyroxine sodium
FDASPLD013974ThyroxineCHEMhas_chemical_structurelevothyroxine
FDASPLN0000175945l-ThyroxineEPChas_epclevothyroxine
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine sodium
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine sodium
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine sodium
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine sodium
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine sodium
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine sodium
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine sodium
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine sodium
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine sodium
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine sodium
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine sodium
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine sodium
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine sodium

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.175 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESVUID4038077
CODESVUID4038822
NAMESPrescribable Synonymlevothyroxine sodium 175 MCG Oral Capsule
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File